Trial Profile
Retrospective cohort study investigating Imatinib adherence and associated clinical outcomes in chronic myeloid leukemia patients in Taiwan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 15 Dec 2015 New trial record